Avicanna Inc. Announces Board Changes
experience in the bio-pharmaceutical industry. Ms. McCormack retired from AstraZeneca US where she
led commercial and cross-functional teams responsible for launch planning and business development in
the US market. Ms. McCormack has experience in bio-pharmaceutical product development, portfolio
strategy in complex regulated environments and brings significant multi-market and international
commercial experience. Ms. McCormack gives back to her community by having served on a number of
national and Toronto-based non-for-profit boards over the last 10 years.